Investigator

Jun Nakayama

Osaka International Cancer Institute, Department of Oncogenesis and Growth Regulation

JNJun Nakayama
Papers(3)
Spatial exosome analy…Ring-Finger Protein 1…Single‐Nucleus <scp>R…
Collaborators(8)
Hiroaki KajiyamaKosuke YoshidaAkira YokoiHiroshi YoshidaKoji OkamotoHirotaka KogaTakao YasuiYusuke Yamamoto
Institutions(6)
Osaka International C…Nagoya UniversitySchool of Medicine, T…Teikyo UniversityJapan Science And Tec…Unknown Institution

Papers

Single‐Nucleus RNA Sequencing and Spatial Transcriptomics for Squamous Cell Carcinoma Arising From Ovarian Mature Teratoma

ABSTRACTSquamous cell carcinoma arising from mature teratoma (SCC‐MT) is a rare ovarian malignancy. The detailed molecular pathology of SCC‐MT is not well understood. Moreover, the prognosis of the patients remains poor because no standard treatment has been established. In this study, we performed single‐nucleus RNA sequencing and spatial transcriptomics using clinical SCC‐MT samples to identify novel therapeutic candidates. snRNA‐seq revealed three epithelial cell clusters, of which one was significantly associated with epidermis and keratinocyte development. Moreover, spatial transcriptomics revealed that the epithelial‐mesenchymal transition was significantly inhibited, and the MYC and E2F targets were significantly activated in cancer spots on specimen sections. We focused on KLF5, which was one of the upregulated genes in cancer cells, and performed a functional analysis using NOSCC‐1, a cell line derived from an SCC‐MT. KLF5 downregulation significantly decreased cell proliferation and increased apoptosis. Furthermore, we previously identified miR‐145‐5p as a downregulated miRNA in SCC‐MT. We demonstrated that miR‐145‐5p overexpression attenuated cell proliferation and decreased KLF5 expression. In conclusion, through multi‐omics analyses, we identified unique gene expression profiles of SCC‐MT and determined a role for KLF5 in SCC‐MT development. Therefore, KLF5‐related factors may be novel therapeutic targets, and further studies are needed to improve the diagnosis and treatment of SCC‐MT.

56Works
3Papers
8Collaborators
Cell Line, TumorBreast NeoplasmsLung NeoplasmsOvarian NeoplasmsApoptosisDisease Models, AnimalColorectal NeoplasmsPrognosis

Positions

2023–

Researcher

Osaka International Cancer Institute · Department of Oncogenesis and Growth Regulation

2020–

Researcher

National Cancer Centre · Division of Cellular Signaling, Laboratory of Integrative Oncology

2020–

Research Fellow

Japan Society for the Promotion of Science

2019–

Assistant Professor

Waseda University · Life Science and Medical Bioscience

2017–

Research Associate

Waseda University · Life Science and Medical Bioscience

Education

2019

Doctor of Science, Ph.D.

Waseda University · Life Science and Medical Bioscience

Country

JP

Keywords
Cellular InformaticsMetastasisDormancySingle-cell AnalysisSingle-cell Meta-analysisTranscriptomeSignal TransductionBioinformaticsMolecular Oncology